Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

http://mc.manuscriptcentral.com/childneurology

Click here to sign up for SAGE Journal Email Alerts today!

Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Winter, S.
Right arrow Articles by Helton, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Winter, S.
Right arrow Articles by Helton, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Role of L-Carnitine in Pediatric Cardiomyopathy

Susan Winter, MD

Genetics/Metabolism, Valley Children's Hospital, 3151 North Millbrook, Fresno, CA

Kenneth Jue, MD

Valley Children's Hospital Fresno, CA

James Prochazka, MD

Valley Children's Hospital Fresno, CA

Paul Francis, MD

Geisinger Medical Center Danville, PA

Wade Hamilton, MD

University of Vermont Medical School, Burlington, VT

Lawrence Linn, MA

Metabolic Research and Analysis, Fresno, CA

Edward Helton, PhD

Sigma-Tau Pharmaceuticals, Gaithersburg, MD

Metabolic and genetic factors underlie some forms of cardiomyopathy in childhood. A variety of inborn errors of metabolism can impair mitochondrial energy production, or β-oxidation, in the heart and lead to myocardial dysfunction. L-Carnitine, an essential element of β-oxidation, transports fatty acids across the mitochondrial membrane for energy production. L-Carnitine deficiency syndromes are now well described as secondary to a variety of inborn errors of metabolism and often include cardiomyopathy in the clinical picture. Despite traditional therapies for cardiomyopathy, mortality for this disorder remains at well over 50%. Review of reports of L-carnitine supplementation studies and results from our own trial underscore the importance of its role in cardiac function and demonstrates that there is likely a subpopulation of patients with cardiomyopathy responsive to L-carnitine treatment. (J Child Neurol 1995; 10(Suppl):2S45-2S5 1).

Journal of Child Neurology, Vol. 10, No. 2 suppl, 2S45-2S51 (1995)
DOI: 10.1177/088307389501000207


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?